Kris Dierickx
New York City Law Department
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kris Dierickx.
Journal of Bioethical Inquiry | 2016
Bege Dauda; Yvonne Denier; Kris Dierickx
The concept of benefit sharing pertains to the act of giving something in return to the participants, communities, and the country that have participated in global health research or bioprospecting activities. One of the key concerns of benefit sharing is the ethical justifications or reasons to support the practice of the concept in global health research and bioprospecting. This article evaluates one of such ethical justifications and its meaning to benefit sharing, namely justice. We conducted a systematic review to map the various principles of justice that are linked to benefit sharing and analysed their meaning to the concept of benefit sharing. Five principles of justice (commutative, distributive, global, procedural, and compensatory) have been shown to be relevant in the nuances of benefit sharing in both global health research and bioprospecting. The review findings indicate that each of these principles of justice provides a different perspective for a different benefit sharing rationale. For example, commutative justice provides a benefit sharing rationale that is focused on fair exchange of benefits between research sponsors and communities. Distributive justice produces a benefit sharing rationale that is focused on improving the health needs of the vulnerable research communities. We have suggested that a good benefit sharing framework particularly in global health research would be more beneficial if it combines all the principles of justice in its formulation. Nonetheless, there is a need for empirical studies to examine the various principles of justice and their nuances in benefit sharing among stakeholders in global health research.
Alzheimer's & Dementia: Translational Research & Clinical Interventions | 2018
Gwendolien Vanderschaeghe; Jolien Schaeverbeke; Rose Bruffaerts; Rik Vandenberghe; Kris Dierickx
In the field of Alzheimers disease research, the use of biomarkers such as amyloid positron emission tomography (PET) has become widespread over a relatively brief period of time. There is an increasing tendency in research studies and trials to switch from no disclosure under any condition toward a qualified disclosure of individual research results, such as amyloid PET scan results. This perspective article aims to evaluate the possible need for a modification of the available recommendations on amyloid PET scan disclosure, based on recent empirical evidence obtained within the field of amyloid PET. This article also applies the International Guideline for Good Clinical Practice to the field of amyloid PET disclosure. Hence, we propose several recommendations to facilitate amyloid PET disclosure while minimizing possible risks of amyloid disclosure in a research context.
Archive | 2009
Kris Dierickx; Pascal Borry
Archive | 2008
Herman Nys; Sarah Defloor; Kris Dierickx; Tom Goffin
Archive | 2012
Gabrielle Christenhusz; Koenraad Devriendt; Kris Dierickx
Abstract book | 2012
Gabrielle Christenhusz; Koenraad Devriendt; Kris Dierickx
Archive | 2011
Gabrielle Christenhusz; Koenraad Devriendt; Kris Dierickx
Archive | 2011
Gert Matthijs; Joris Vermeesch; Jan Aerts; Pascal Borry; Koenraad Devriendt; Kris Dierickx; Yves Moreau; Erik Schokkaert; Ann Swillen; Hilde Van Esch; Griet Verhenneman
Archive | 2010
M. Proesmans; Harry Cuppens; Marie-Françoise Vincent; Alain Palem; K De Boeck; Kris Dierickx; Herman Nys; Mattias Neyt; Imgard Vinck; Patrick Lebecque
Ethische Perspectieven: Nieuwsbrief van het Overlegcentrum voor Ethiek | 2010
Wim Pinxten; Herman Nys; Kris Dierickx